LaNCE-Neuropharm - GIC 21/133
Clínica Universitaria de Navarra
Pamplona, EspañaClínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2022
-
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies
Frontiers in Neurology, Vol. 13
2021
-
Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations
Molecular Therapy - Nucleic Acids, Vol. 25, pp. 585-602
2019
-
Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers
Parkinsonism and Related Disorders, Vol. 65, pp. 139-145
2012
-
levodopa en el tratamiento de la enfermedad de parkinson: Mitos y realidades
Revista de Neurologia, Vol. 55, Núm. 11, pp. 669-688
2007
-
Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways
Journal of Molecular Neuroscience, Vol. 32, Núm. 1, pp. 53-63